Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-164,895
Closed -$8.01M 3
2020
Q4
$8.01M Buy
164,895
+79,419
+93% +$3.92M 7.51% 2
2020
Q3
$4.29M Sell
85,476
-427,584
-83% -$22M 83.82% 1
2020
Q2
$26.2M Buy
513,060
+63,060
+14% +$3.06M 93.05% 1
2020
Q1
$19.7M Hold
450,000
97.05% 1
2019
Q4
$22.6M Hold
450,000
96.64% 1
2019
Q3
$20.8M Hold
450,000
96.92% 1
2019
Q2
$19.5M Hold
450,000
96.25% 1
2019
Q1
$19.9M Hold
450,000
13.38% 2
2018
Q4
$19.5M Hold
450,000
14.16% 2
2018
Q3
$20.1M Hold
450,000
13.33% 2
2018
Q2
$18M Hold
450,000
7.57% 7
2018
Q1
$18M Hold
450,000
7.84% 4
2017
Q4
$19.4M Hold
450,000
8.42% 3
2017
Q3
$22.4M Hold
450,000
9.77% 2
2017
Q2
$21.6M Hold
450,000
9.16% 2
2017
Q1
$20.4M Hold
450,000
8.79% 3
2016
Q4
$18.2M Hold
450,000
7.99% 3
2016
Q3
$17.2M Hold
450,000
7.79% 4
2016
Q2
$18.8M Hold
450,000
8.14% 2
2016
Q1
$18.1M Buy
+450,000
New +$18.1M 4.92% 1

Other funds holding SNY

Chubb Ltd's SNY Position: Q1 2021 in Review

Chubb Ltd sold out of Sanofi (SNY) in Q1 2021, closing a stake of 164,895 shares — an estimated $8.01M sold.

Chubb Ltd first reported a position in SNY in Q1 2016 and held it in 20 quarters. The position peaked at $26.2M in Q2 2020. 573 funds tracked by Wall St. Rank hold SNY as of Q1 2021.

  • Chubb Ltd reported no remaining Sanofi position as of Q1 2021 after selling out during the quarter.
  • Chubb Ltd sold 164,895 Sanofi shares in Q1 2021, an estimated $8.01M.
  • Chubb Ltd first reported a position in Sanofi in Q1 2016 and held it in 20 quarters.
  • Chubb Ltd's Sanofi position peaked at $26.2M in Q2 2020.
  • 573 funds tracked by Wall St. Rank held Sanofi as of Q1 2021.

Based on Chubb Ltd's 13F filing for Q1 2021, filed 5 May 2021.